Farther Finance Advisors’s Perspective Therapeutics CATX Stock Holding History

Farther Finance Advisors’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-348	Closed	-$1.19K	–	6179
2026 Q2	$1.19K	Hold	348	–	–	﹤0.01%	5327
2026 Q1	$1.54K	Sell	348 -3	-0.9%	-$13	﹤0.01%	4989
2025 Q4	$965	Buy	351 +3	+0.9%	+$9	﹤0.01%	4920
2025 Q3	$1.19K	Hold	348	–	–	﹤0.01%	4317
2025 Q2	$1.2K	Hold	348	–	–	﹤0.01%	3857
2025 Q1	$682	Hold	348	–	–	﹤0.01%	3718
2024 Q4	$1.11K	Hold	348	–	–	﹤0.01%	3215
2024 Q3	$4.65K	Hold	348	–	–	﹤0.01%	2678
2024 Q2	$3.9K	Buy	+348	New	+$5.03K	﹤0.01%	2503

Other funds holding CATX

TMWM

Taylor & Morgan Wealth Management Flint, Michigan $208M AUM 15.78% 1-Year Est. Return

ISB

Iowa State Bank Urbandale, Iowa $592M AUM 21.15% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's CATX Position: Q3 2026 in Review

Farther Finance Advisors sold out of Perspective Therapeutics (CATX) in Q3 2026, closing a stake of 348 shares — an estimated $1.19K sold.

Farther Finance Advisors first reported a position in CATX in Q2 2024 and held it in 9 quarters. The position peaked at $4.65K in Q3 2024. 3 funds tracked by Wall St. Rank hold CATX as of Q3 2026.

Farther Finance Advisors reported no remaining Perspective Therapeutics position as of Q3 2026 after selling out during the quarter.
Farther Finance Advisors sold 348 Perspective Therapeutics shares in Q3 2026, an estimated $1.19K.
Farther Finance Advisors first reported a position in Perspective Therapeutics in Q2 2024 and held it in 9 quarters.
Farther Finance Advisors's Perspective Therapeutics position peaked at $4.65K in Q3 2024.
3 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.